Literature DB >> 21048052

Should anticoagulation be resumed after intracerebral hemorrhage?

Joshua N Goldstein1, Steven M Greenberg.   

Abstract

Intracerebral hemorrhage (ICH) is the most feared and the most deadly complication of oral anticoagulant therapy, eg, with warfarin (Coumadin). After such an event, clinicians wonder whether their patients should resume anticoagulant therapy. The authors review the management of anticoagulation during and after anticoagulation-associated ICH.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21048052      PMCID： PMC3684182          DOI： 10.3949/ccjm.77a.10018

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  84 in total

1.  Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage.

Authors:  Daniel O Claassen; Noojan Kazemi; Alexander Y Zubkov; Eelco F M Wijdicks; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2008-10

2.  Warfarin use leads to larger intracerebral hematomas.

Authors:  M L Flaherty; H Tao; M Haverbusch; P Sekar; D Kleindorfer; B Kissela; P Khatri; B Stettler; O Adeoye; C J Moomaw; J P Broderick; D Woo
Journal:  Neurology       Date:  2008-09-30       Impact factor: 9.910

3.  Hematoma growth in oral anticoagulant related intracerebral hemorrhage.

Authors:  Brett Cucchiara; Steven Messe; Lauren Sansing; Scott Kasner; Patrick Lyden
Journal:  Stroke       Date:  2008-08-14       Impact factor: 7.914

4.  Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Sam Schulman; Rebecca J Beyth; Clive Kearon; Mark N Levine
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

5.  Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Margaret C Fang; Alan S Go; Jonathan L Halperin; Gregory Y H Lip; Warren J Manning
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

6.  Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Gregory W Albers; Pierre Amarenco; J Donald Easton; Ralph L Sacco; Philip Teal
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

7.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 8.  Warfarin reversal in anticoagulant-associated intracerebral hemorrhage.

Authors:  Joshua N Goldstein; Jonathan Rosand; Lee H Schwamm
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

9.  Association between cerebral microbleeds on T2*-weighted MR images and recurrent hemorrhagic stroke in patients treated with warfarin following ischemic stroke.

Authors:  H Ueno; H Naka; T Ohshita; K Kondo; E Nomura; T Ohtsuki; T Kohriyama; S Wakabayashi; M Matsumoto
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

Review 10.  Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity.

Authors:  Michael C Christensen; Jesse Dawson; Catherine Vincent
Journal:  Adv Ther       Date:  2008-09       Impact factor: 3.845
View more
  25 in total

1.  Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding.

Authors:  Prashanth Panduranga; Mohammed Al-Mukhaini; Muhanna Al-Muslahi; Mohammed A Haque; Abdullah Shehab
Journal:  World J Cardiol       Date:  2012-03-26

2.  Practical Guide to Direct New Oral Anticoagulant Use for Secondary Stroke Prevention in Atrial Fibrillation.

Authors:  Rochelle Sweis; José Biller
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

3.  Safety of catheter ablation for atrial fibrillation in patients with intracranial hemorrhage.

Authors:  H Lin; S-N Li; R Bai; S-N Wen; N Liu; D-Y Long; R-H Yu; R-B Tang; C-H Sang; X Du; J-Z Dong; C-S Ma
Journal:  Herz       Date:  2017-03-17       Impact factor: 1.443

4.  Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage.

Authors:  Robert J Stanton; Mark H Eckman; Daniel Woo; Charles J Moomaw; Mary Haverbusch; Matthew L Flaherty; Dawn O Kleindorfer
Journal:  Stroke       Date:  2020-01-31       Impact factor: 7.914

5.  Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases.

Authors:  Maged D Fam; Alice Pang; Hussein A Zeineddine; Steven Mayo; Agnieszka Stadnik; Michael Jesselson; Lingjiao Zhang; Rachel Dlugash; Wendy Ziai; Daniel Hanley; Issam A Awad
Journal:  Cerebrovasc Dis       Date:  2017-02-28       Impact factor: 2.762

Review 6.  Therapeutic strategies in acute intracerebral hemorrhage.

Authors:  H Bart Brouwers; Joshua N Goldstein
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

7.  Initiating anticoagulant therapy after ICH is associated with patient characteristics and treatment recommendations.

Authors:  Jochen A Sembill; Claudia Y Wieser; Maximilian I Sprügel; Stefan T Gerner; Antje Giede-Jeppe; Caroline Reindl; Ilker Y Eyüpoglu; Philip Hoelter; Hannes Lücking; Joji B Kuramatsu; Hagen B Huttner
Journal:  J Neurol       Date:  2018-08-20       Impact factor: 4.849

Review 8.  Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation.

Authors:  Eleni Korompoki; Filippos T Filippidis; Peter B Nielsen; Angela Del Giudice; Gregory Y H Lip; Joji B Kuramatsu; Hagen B Huttner; Jiming Fang; Sam Schulman; Joan Martí-Fàbregas; Celine S Gathier; Anand Viswanathan; Alessandro Biffi; Daniela Poli; Christian Weimar; Uwe Malzahn; Peter Heuschmann; Roland Veltkamp
Journal:  Neurology       Date:  2017-07-19       Impact factor: 9.910

9.  Neurologic complications of infective endocarditis.

Authors:  Amy A Pruitt
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

10.  Management of thrombocytopenia in a patient with a mechanical mitral valve undergoing autologous hematopoietic stem cell transplantation: case report and review of literature.

Authors:  Gregory Miller; Samuel B Reynolds; William W Tse
Journal:  Am J Blood Res       Date:  2020-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.